The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation

A proteomics analysis identifies one third of the predicted Toxoplasma gondii proteins and integrates proteomics and genomics data to refine genome annotation

Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases

Urinary tract disease is a common reason for use (and likely misuse, improper use, and overuse) of antimicrobials in dogs and cats. There is a lack of comprehensive treatment guidelines such as those that are available for human medicine. Accordingly, guidelines for diagnosis and management of urinary tract infections were created by a Working Group of the International Society for Companion Animal Infectious Diseases. While objective data are currently limited, these guidelines provide information to assist in the diagnosis and management of upper and lower urinary tract infections in dogs and cats

Aquavet®: A Program in Aquatic Veterinary Medicine

Aquavet®: [Internet resource] A Program in Aquatic Veterinary http://www.vet.cornell.edu/aquavet/ Snapshot taken on November 30, 2011Contents include: General Information; [Course description of] Aquavet I: Introduction to Aquatic Veterinary Medicine; [Course description of] Aquavet II: Comparative Pathology of Aquatic Animals; Summer Research; Faculty; Locale and Facilities; Equipment and Supplies; Application; 2012 Aquavet Program; Travel Information

AQUAVET: A Program in Aquatic Animal Medicine

[24] p. : illus., 15.5 x 23 cm.Topics include: Contents; Aquavet; Basic Course; Advanced Courses; Summer Research; Faculty; Credit; Locale and Facilities; Equipment and Supplies; Cost; Admission; Application and Further Information

Proceedings of the AQUAVET 20th Anniversary Conference, Marine Biological Laboratory, Woods Hole, Massachusetts, November 14-17, 1996

Proceedings of the AQUAVET 20th Anniversary Conference, Marine Biological Laboratory, Woods Hole, Massachusetts, November 14-17, 1996Contents include: Forward (Donald A. Abt, Paul R. Bowser, Laurie J. Landeau); Conference Schedule; Table of Contents: List of Participants; Session Schedules: Sessions I and II, Sessions III and IV; Sessions V and VI, Posters; Proceedings Abstracts; Reflections on 20 Years (1977-1996) of AQUAVET

Coagulation abnormalities and complications after percutaneous liver biopsy in horses

Background: Liver biopsy is useful in the diagnosis of liver disease in horses. However, bleeding is the major complication. Liver dysfunction can result in abnormalities in coagulation, although there is no definitive association between risk of hemorrhage after biopsy and coagulopathy in humans. Frequency of coagulopathies in horses with liver disease and the nature and frequency of complications after liver biopsy are not reported. Hypothesis/Objectives: To determine whether there is an association between coagulopathy and hemorrhage after liver biopsy in horses. Animals: Horses with suspected liver disease from which a liver biopsy had been obtained. Methods: Retrospective study. Variables indicative of coagulation were recorded. The frequency and nature of complications after biopsy were assessed using clinical and hematologic data. The association between abnormal coagulation variables and complications was assessed. Results: Seventy biopsies were obtained from 66 horses. At least 1 coagulation profile abnormality was identified in 58% of the 43 horses with histopathologically confirmed liver disease. Complications were observed in 4/32 monitored horses (33 biopsies). Three horses had a decrease in the packed cell volume suggestive of subclinical bleeding, and 1 horse developed a diaphragmatic hematoma. There was no association between coagulation profile abnormality and complications. Conclusion and Clinical Importance: Abnormalities of coagulation are common in horses with liver disease. Liver biopsy appears to be a safe procedure in the horse. An abnormal coagulation profile is not clearly associated with an increased risk of complications after biopsy